Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹25 Cr₹-69 Cr₹-136 Cr₹38 Cr₹-114 Cr

What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES is ₹25 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹25 Cr
Mar2024₹-69 Cr
Mar2023₹-136 Cr
Mar2022₹38 Cr
Mar2021₹-114 Cr

How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹25 Cr
Positive
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹-136 Cr
Negative
Mar2022 ₹38 Cr
Positive
Mar2021 ₹-114 Cr -

Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,392.7 Cr -6.2% -3.3% 20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-6.2%

-3.3%

20.1%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses